Literature DB >> 17910962

Urinary adrenalin and cortisol secretion patterns of social voles in response to adrenergic blockade under basal conditions.

Abed Elsalam Zubidat1, Randy J Nelson, Abraham Haim.   

Abstract

The effect of alpha(1)- and beta-adrenergic blockade on daily rhythms of urinary adrenalin (ADR) and cortisol (CORT) under basal conditions were evaluated. Voles acclimated to a 12:12 h light/dark cycle at 26+/-2 degrees C received a single dose of either propranolol (PROP; 4.5 mg/kg) or prazosin (PRAZ; 1 mg/kg) 1 h before lights off. Urine samples were collected for 24 h at 4 h intervals. PROP evokes a significant increase in mean urinary ADR; although CORT was unaffected by PROP, PRAZ administration significantly decreased both urinary ADR and CORT during the scotophase as compared with control voles. Cosinor analysis indicated a significant 24 h rhythm in urinary ADR, but not in CORT secretion. ADR mesor and amplitude were increased and acrophase was significantly delayed by 5 h in PROP-treated voles; PRAZ elicited opposite effects. Unexpectedly, these changes in the 24 h ADR rhythm persisted 4-weeks after PROP-treatment. The 24 h rhythm components of urinary CORT were marginally altered 4-weeks post-PROP, but only the acrophase showed a significant change. Collectively, the results indicate that sympathetic activity has a redundant compensatory mechanism defending against physiological changes induced by beta-blockade. The simultaneous decrease in adrenal hormones induced by PRAZ suggests that alpha(1)-adrenoceptors may contribute to the mechanism of integrated stress responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910962     DOI: 10.1016/j.physbeh.2007.08.024

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  1 in total

1.  The role of alpha-1 and alpha-2 adrenoceptors in restraint stress-induced liver injury in mice.

Authors:  Qing Zhu; Liwei Gu; Yimei Wang; Li Jia; Zengming Zhao; Shuangqing Peng; Linsheng Lei
Journal:  PLoS One       Date:  2014-03-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.